ConductScience.org, home

Paper28097409

Genetic and Epigenetic Intra-tumour Heterogeneity in Colorectal Cancer.

Jones HG and 6 others. World J Surg, 2017. Cited by 23 papers, by iCite.

Cite this record

ConductScience Library. Genetic and Epigenetic Intra-tumour Heterogeneity in Colorectal Cancer. Papers, record 28097409. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28097409

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Genetic and Epigenetic Intra-tumour Heterogeneity in Colorectal Cancer.
PubMed
Journal
World J Surg
PubMed
Year
2017
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
23
iCite
Relative citation ratio, by iCite
0.65
iCite
Revised in PubMed
2025-05-30
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jones HGHuw Gerainthttps://orcid.org/0000-0003-0365-9049
2Jenkins GGareth
3Williams NNamor
4Griffiths PPaul
5Chambers PPhil
6Beynon JJohn
7Harris DDean

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Colorectal NeoplasmsMajor topic
CpG IslandsMajor topic
Proto-Oncogene Proteins B-rafMajor topic
Proto-Oncogene Proteins p21(ras)Major topic
Aged
Aged, 80 and over
DNA, Neoplasm
Female
Humans
Male
Middle Aged
Mutation
Phenotype

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
15956Cancer Research UKUnited KingdomPubMed

Source PubMed

Download CSV of grants

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119737509Heterogeneity in cancer: cancer stem cells versus clonal evolution.Cell2009https://conductscience.org/library/papers/19737509PubMed
222513401Intra-tumour heterogeneity: a looking glass for cancer?Nat Rev Cancer2012https://conductscience.org/library/papers/22513401PubMed
319931353Tumor heterogeneity: causes and consequences.Biochim Biophys Acta2010https://conductscience.org/library/papers/19931353PubMed
425042786Single-cell genome-wide bisulfite sequencing for assessing epigenetic heterogeneity.Nat Methods2014https://conductscience.org/library/papers/25042786PubMed
53802089Growth properties of artificial heterogeneous human colon tumors.Cancer Res1987https://conductscience.org/library/papers/3802089PubMed
617204026Classification of colorectal cancer based on correlation of clinical, morphological and molecular features.Histopathology2007https://conductscience.org/library/papers/17204026PubMed
721483104Intra-tumoral heterogeneity of KRAS and BRAF mutation status in patients with advanced colorectal cancer (aCRC) and cost-effectiveness of multiple sample testing.Anal Cell Pathol (Amst)2011https://conductscience.org/library/papers/21483104PubMed
822882224The utility of diagnostic biopsy specimens for predictive molecular testing in colorectal cancer.Histopathology2012https://conductscience.org/library/papers/22882224PubMed
919269522Barrett's oesophagus.Lancet2009https://conductscience.org/library/papers/19269522PubMed
1011433398Intratumor genetic heterogeneity in advanced human colorectal adenocarcinoma.Int J Cancer2001https://conductscience.org/library/papers/11433398PubMed
1122397650Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.N Engl J Med2012https://conductscience.org/library/papers/22397650PubMed
1221163703KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer.Lancet Oncol2011https://conductscience.org/library/papers/21163703PubMed
1319884549KRAS and BRAF mutations in advanced colorectal cancer are associated with poor prognosis but do not preclude benefit from oxaliplatin or irinotecan: results from the MRC FOCUS trial.J Clin Oncol2009https://conductscience.org/library/papers/19884549PubMed
1424352906Tumor heterogeneity revealed by KRAS, BRAF, and PIK3CA pyrosequencing: KRAS and PIK3CA intratumor mutation profile differences and their therapeutic implications.Hum Mutat2014https://conductscience.org/library/papers/24352906PubMed
152188735A genetic model for colorectal tumorigenesis.Cell1990https://conductscience.org/library/papers/2188735PubMed
1622469128Genetic heterogeneity and cancer drug resistance.Lancet Oncol2012https://conductscience.org/library/papers/22469128PubMed
1721160474Genetic variegation of clonal architecture and propagating cells in leukaemia.Nature2011https://conductscience.org/library/papers/21160474PubMed
1821941284A decade of exploring the cancer epigenome - biological and translational implications.Nat Rev Cancer2011https://conductscience.org/library/papers/21941284PubMed
1916369569The epigenetic progenitor origin of human cancer.Nat Rev Genet2006https://conductscience.org/library/papers/16369569PubMed
2020028768Three DNA methylation epigenotypes in human colorectal cancer.Clin Cancer Res2010https://conductscience.org/library/papers/20028768PubMed

See all 26 referencesDownload CSV of references

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.

PMIDTitleJournalYearIn PapersSource
41768137Antibody-drug conjugates in colorectal cancer: advances in targeted delivery and personalized oncology.Front Bioeng Biotechnol2026https://conductscience.org/library/papers/41768137PubMed
40302146Search for Mutations Connected With Non-Response to Anti-EGFR Therapy in mCRC in the Morphologically Defined Regions of Primary Tumours.Cancer Med2025https://conductscience.org/library/papers/40302146PubMed
39539964Unveiling the dynamics of circulating tumor cells in colorectal cancer: from biology to clinical applications.Front Cell Dev Biol2024https://conductscience.org/library/papers/39539964PubMed
36313449The role of a cuproptosis-related prognostic signature in colon cancer tumor microenvironment and immune responses.Front Genet2022https://conductscience.org/library/papers/36313449PubMed
36064367Identification of genes with high heterogeneity of expression as a predictor of different prognosis and therapeutic responses in colorectal cancer: a challenge and a strategy.Cancer Cell Int2022https://conductscience.org/library/papers/36064367PubMed
35454843Application of mTORC1 Inhibitors for Tissue-Agnostic Management of Standard-Therapy-Refractory Solid Tumors.Cancers (Basel)2022https://conductscience.org/library/papers/35454843PubMed
35194184Prediction of lymph node metastasis in early colorectal cancer based on histologic images by artificial intelligence.Sci Rep2022https://conductscience.org/library/papers/35194184PubMed
34888246Personalized Immunotherapy in Colorectal Cancers: Where Do We Stand?Front Oncol2021https://conductscience.org/library/papers/34888246PubMed
34485122Evaluation of the Impact of Intratumoral Heterogeneity of Esophageal Cancer on Pathological Diagnosis and P16 Methylation and the Representativity of Endoscopic Biopsy.Front Oncol2021https://conductscience.org/library/papers/34485122PubMed
34346563Improving the overall survival prognosis prediction accuracy: A 9-gene signature in CRC patients.Cancer Med2021https://conductscience.org/library/papers/34346563PubMed
34030582Mapping the colorectal tumor microbiota.Gut Microbes2021https://conductscience.org/library/papers/34030582PubMed
33322358Precision Medicine for the Management of Therapy Refractory Colorectal Cancer.J Pers Med2020https://conductscience.org/library/papers/33322358PubMed
33284993Multiregional assessment of CIMP in primary colorectal cancers: Phenotype concordance but marker variability.Int J Cancer2021https://conductscience.org/library/papers/33284993PubMed
32853464Intratumor heterogeneity: A new perspective on colorectal cancer research.Cancer Med2020https://conductscience.org/library/papers/32853464PubMed
31892859Identifying a ten-microRNA signature as a superior prognosis biomarker in colon adenocarcinoma.Cancer Cell Int2019https://conductscience.org/library/papers/31892859PubMed
31623592Global differences in the prevalence of the CpG island methylator phenotype of colorectal cancer.BMC Cancer2019https://conductscience.org/library/papers/31623592PubMed
30477151Heterogeneity in Colorectal Cancer: A Challenge for Personalized Medicine?Int J Mol Sci2018https://conductscience.org/library/papers/30477151PubMed
30405408Impact of Global DNA Methylation in Treatment Outcome of Colorectal Cancer Patients.Front Pharmacol2018https://conductscience.org/library/papers/30405408PubMed
30171333The gene mutational discrepancies between primary and paired metastatic colorectal carcinoma detected by next-generation sequencing.J Cancer Res Clin Oncol2018https://conductscience.org/library/papers/30171333PubMed
29947019Nanogel-mediated delivery of a cocktail of epigenetic drugs plus doxorubicin overcomes drug resistance in breast cancer cells.Drug Deliv Transl Res2018https://conductscience.org/library/papers/29947019PubMed

See all 21 cited byDownload CSV of cited by

Genes12

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28097409

GET https://conductscience.org/api/papers/v1/28097409/references?page=2